Share
Journal Information
Issue
Vol. 21. (March - April 2021)
Editorial
Concise reviews
STAT3: A key regulator in liver fibrosis
Jie Zhao, Yong-Fen Qi, Yan-Rong Yu
Ann Hepatol. 2021;21C:224
Open access
Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations
Carolina Delgado Martínez, Mariano Gómez-Rubio, Cecilia Gómez-Domínguez
Ann Hepatol. 2021;21C:225
Open access
Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease
Guillermo Nahúm López-Sánchez, Mayra Dóminguez-Pérez, Misael Uribe, Norberto Carlos Chávez-Tapia, Natalia Nuño-Lámbarri
Ann Hepatol. 2021;21C:212
Open access
Original articles
Non-invasive diagnosis of non-alcoholic fatty liver disease using an algorithm combining clinical indexes and ultrasonographic measures
Monica C. Preciado-Puga, Yeniley Ruiz-Noa, Juana R. Garcia-Ramirez, Benjamin Jordan-Perez, Serafin Garnelo-Cabañas, Maria L. Lazo de la Vega-Monroy, Karen I. Gutierrez-Aguirre, Lorena R. Ibarra-Reynoso
Ann Hepatol. 2021;21C:264
Open access
Temporal histopathological changes in biliary atresia: A perspective for rapid fibrosis progression
Hanaa A El-Araby, Magdy A Saber, Noha M Radwan, Doha M Taie, Nermin M Adawy, Ahmad M Sira
Ann Hepatol. 2021;21C:263
Highlights
- •
Liver fibrosis in biliary atresia (BA) progresses within a short time.
- •
A younger infant with BA could exhibit a higher grade of fibrosis.
- •
Pathological findings in BA are well studied, but there are very few studies regarding temporal changes.
- •
Bile ductular proliferation was the only independent feature showing temporal increase.
Open access
Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines
Jiaqi Yang, David Sontag, Yuewen Gong, Gerald Y. Minuk
Ann Hepatol. 2021;21C:265
Open access
The histone variant H3.3 regulates the transcription of the hepatitis B virus
Francisca Alvarez-Astudillo, Daniel Garrido, Manuel Varas-Godoy, José Leonardo Gutiérrez, Rodrigo A. Villanueva, Alejandra Loyola
Ann Hepatol. 2021;21C:261
Open access
Outcomes of Japanese patients with non-alcoholic fatty liver disease according to genetic background and lifestyle-related diseases
Tomomi Kogiso, Takaomi Sagawa, Kazuhisa Kodama, Makiko Taniai, Etsuko Hashimoto, Katsutoshi Tokushige
Ann Hepatol. 2021;21C:260
Open access
miRNA-338-3p/CAMK IIα signaling pathway prevents acetaminophen-induced acute liver inflammation in vivo
Chen Zhang, Li Kang, Haihui Zhu, Jing Li, Rong Fang
Ann Hepatol. 2021;21C:191
Open access
Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission
Manuel Mendizabal, Federico Piñero, Ezequiel Ridruejo, Margarita Anders, María Dolores Silveyra, Aldo Torre, Pedro Montes, Alvaro Urzúa, ... Marcelo O Silva
Ann Hepatol. 2021;21C:100298
Open access
Open Article
Prognostic value of liver biochemical parameters for COVID-19 mortality
Lin Ye, Bin Chen, Yitong Wang, Yi Yang, Jiling Zeng, Guangtong Deng, Yuhao Deng, Furong Zeng
Ann Hepatol. 2021;21C:279
Open access
Open Article
Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19
Amer Hamadé, Bastien Woehl, Marjolaine Talbot, Naouel Bensalah, Pierre Michel, Golnaz Obringer, Michèle Lehn-Hogg, Nathalie Buschenrieder, ... Lucas Jambert
Ann Hepatol. 2021;21C:274
Open access
Open Article
Liver disease and outcomes among COVID-19 hospitalized patients – A systematic review and meta-analysis
Ashish Sharma, Pragya Jaiswal, Yasameen Kerakhan, Lakshmi Saravanan, Zeba Murtaza, Azka Zergham, Nagaraj-Sanchitha Honganur, Aelia Akbar, ... Preeti Malik
Ann Hepatol. 2021;21C:273
Open access
Open Article
Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases
Faxiang Chen, Wei Chen, Jianpu Chen, Dan Xu, Wei Xie, Xiang Wang, Yuanliang Xie
Ann Hepatol. 2021;21C:267
Open access
Open Article
Case report
Laparoscopic repair of transected right hepatic artery during cholecystectomy: A report of two cases
Wu Bao-Qiang, Hu Jun, Liu Wen-Song, Jiang Yong, Chen Xue-Min, Sun Dong-Lin
Ann Hepatol. 2021;21C:161
Open access
Aggressive recurrence of Non-Hodgkin's Lymphoma after successful clearance of hepatitis C virus with direct acting antivirals
Dimitrios N. Samonakis, Maria Psyllaki, Konstantia I. Pavlaki, Elias Drakos, Elias Kehagias, Maria Tzardi, Helen A. Papadaki
Ann Hepatol. 2021;21C:141
Open access
Liver transplantation in acute liver failure due to Hepatitis B. Two clinical cases
Rocío Sedano, Lorena Castro, Mauricio Venegas, Julio Miranda, Carmen Hurtado, Jaime Poniachik, Javier Brahm
Ann Hepatol. 2021;21C:107
Open access
Letters to the editor
Renal and brain failure predict mortality of patients with acute-on-chronic liver failure admitted to the intensive care unit
Shishi Ying, Xiaofei Li
Ann Hepatol. 2021;21C:100296
Open access
Renal and brain failure predict mortality of patients with acute-on-chronic liver failure admitted to the intensive care unit
Aldo Torre
Ann Hepatol. 2021;21C:100308
Open access
New model predicting gastroesophageal varices and variceal hemorrhage in patients with chronic liver disease
Yongxin Chen, Xiaofei Li
Ann Hepatol. 2021;21C:275
Open access
In Reply
Ling-ling He, Jia-li Ma, Yu Jiang, Jun-ru Yang, Ping Li, Yao Zhang, Hong-shan Wei
Ann Hepatol. 2021;21C:100313
Open access
Hepatocellular carcinoma treatment with Sorafenib: A remarkable case of eight-years remission without significant toxicity
Ana L. Santos, Hélder Cardoso, Marco Silva, Adriana Moreira, Guilherme Macedo
Ann Hepatol. 2021;21C:116
Open access
Publish in
Annals of Hepatology
Affiliated societies
